Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831125 · ClinicalTrials.gov registry record
Conduction System Pacing International Registry (CONSPIRE)
A clinical trial of Heart Failure and Bradyarrhythmia, sponsored by University of Chicago.
- Completed
- Registry status
- 383
- Enrollment target
- 8
- Study locations
NCT04831125 is a study of Heart Failure and Bradyarrhythmia that has completed, run by University of Chicago. The registered enrollment target is 383 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (81% lower). The trial reports 8 study locations across 5 states.
The verdict
NCT04831125, a study of Heart Failure and Bradyarrhythmia, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 383 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this registry study is to collect information about routine clinical practices with device implantation to treat bradycardia and cardiac systolic dysfunction (heart rhythm disorders) across global centers of excellence in cardiac pacing. In particular, this study will examine the use of conduction system pacing (CSP) in clinical practice. Information collected in the registry will help researchers better characterize strengths and limitations of current technology and treatments.
Conditions Studied
Interventions
- OTHER Data collection
Study Locations (8)
Other
- Maastricht University Medical Center - Maastricht
- Health Research Institute Hospital La Fe - Valencia
- Lund University - Lund
Pennsylvania
- University of Pennsylvania - Philadelphia
- Geisinger Wyoming Valley Medical Center - Wilkes-Barre
Arizona
- University of Arizona - Tucson
Illinois
- University of Chicago - Chicago
New York
- Icahn School of Medicine at Mount Sinai & Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2021-04-04 |
| Est. Completion | 2026-02-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04831125
The ClinicalTrials.gov registry entry for NCT04831125 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 383 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (81% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Data collection is the first listed.
NCT04831125 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Other, Pennsylvania, Arizona.
Frequently Asked Questions
What is clinical trial NCT04831125 about?
NCT04831125 is a clinical study titled "Conduction System Pacing International Registry (CONSPIRE)". The purpose of this registry study is to collect information about routine clinical practices with device implantation to treat bradycardia and cardiac systolic dysfunction (heart rhythm disorders) across global centers of excellence in cardiac pacing. In particular, this study will examine the use ...
What is the current status of trial NCT04831125?
This trial is currently completed. The enrollment target is 383 participants. The study started on 2021-04-04. Estimated completion is 2026-02-05.
What conditions does trial NCT04831125 study?
This clinical trial studies the following conditions: Heart Failure, Bradyarrhythmia.
What interventions are being tested in trial NCT04831125?
The interventions under investigation include: Data collection (OTHER).
Who is sponsoring clinical trial NCT04831125?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04831125 being conducted?
This trial has 8 study locations across Arizona, Illinois, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.